Works matching IS 15257304 AND DT 2021 AND VI 22 AND IP 6

Results: 34

Table of Contents.

Published in:: Clinical Lung Cancer, 2021, v. 22, n. 6, p. A3, doi. 10.1016/S1525-7304(21)00258-8
Publication type:: Article

Editorial Board.

Published in:: Clinical Lung Cancer, 2021, v. 22, n. 6, p. A1, doi. 10.1016/S1525-7304(21)00257-6
Publication type:: Article

Molecular Risk Stratification is Independent of EGFR Mutation Status in Identifying Early-Stage Non–Squamous Non–Small Cell Lung Cancer Patients at Risk for Recurrence and Likely to Benefit From Adjuvant Chemotherapy.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. 587, doi. 10.1016/j.cllc.2021.08.008

By:

Woodard, Gavitt A.;
Kratz, Johannes R.;
Haro, Greg;
Gubens, Matthew A.;
Blakely, Collin M.;
Jones, Kirk D.;
Mann, Michael J.;
Jablons, David M.

Publication type:

Article

Role of Postoperative Radiotherapy in the Management for Resected NSCLC – Decision Criteria in Clinical Routine Pre- and Post-LungART.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. 579, doi. 10.1016/j.cllc.2021.08.007

By:

Süveg, Krisztian;
Le Pechoux, Cecile;
Faivre-Finn, Corinne;
Putora, Paul M.;
De Ruysscher, Dirk;
Widder, Joachim;
Van Houtte, Paul;
Troost, Esther G.C.;
Slotman, Ben J.;
Ramella, Sara;
Pöttgen, Christoph;
Peeters, Stephanie T.H.;
Nestle, Ursula;
McDonald, Fiona;
Dziadziuszko, Rafal;
Belderbos, José;
Ricardi, Umberto;
Manapov, Farkhad;
Lievens, Yolande;
Geets, Xavier

Publication type:

Article

Antibody Drug Conjugates in Lung Cancer: State of the Current Therapeutic Landscape and Future Developments.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. 483, doi. 10.1016/j.cllc.2021.07.011

By:

Reuss, Joshua E.;
Gosa, Laura;
Liu, Stephen V.

Publication type:

Article

Biomarker-Directed Phase II Platform Study in Patients With EGFR Sensitizing Mutation-Positive Advanced/Metastatic Non-Small Cell Lung Cancer Whose Disease Has Progressed on First-Line Osimertinib Therapy (ORCHARD).

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. 601, doi. 10.1016/j.cllc.2021.06.006

By:

Yu, Helena A.;
Goldberg, Sarah B.;
Le, Xiuning;
Piotrowska, Zofia;
Goldman, Jonathan W.;
De Langen, Adrianus J.;
Okamoto, Isamu;
Cho, Byoung Chul;
Smith, Paul;
Mensi, Ilhem;
Ambrose, Helen;
Kraljevic, Silvija;
Maidment, Julie;
Chmielecki, Juliann;
Li-Sucholeiki, Xiaocheng;
Doughton, Gail;
Patel, Gargi;
Jewsbury, Phil;
Szekeres, Phil;
Riess, Jonathan W.

Publication type:

Article

Significance of Brain Imaging for Staging in Patients With Clinical Stage T1-2 N0 Non–Small-Cell Lung Cancer on Positron Emission Tomography/Computed Tomography.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. 562, doi. 10.1016/j.cllc.2021.06.004

By:

Saito, Go;
Kono, Masato;
Koyanagi, Yu;
Miyashita, Koichi;
Tsutsumi, Akari;
Kobayashi, Takeshi;
Miki, Yoshihiro;
Hashimoto, Dai;
Nakamura, Toru;
Nozue, Masashi;
Nakamura, Hidenori

Publication type:

Article

Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients With Unresectable Stage III Non–Small–Cell Lung Cancer (PACIFIC).

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. 549, doi. 10.1016/j.cllc.2021.05.009

By:

Socinski, Mark A.;
Özgüroğlu, Mustafa;
Villegas, Augusto;
Daniel, Davey;
Vicente, David;
Murakami, Shuji;
Hui, Rina;
Gray, Jhanelle E.;
Park, Keunchil;
Vincent, Mark;
Mann, Helen;
Newton, Michael;
Dennis, Phillip A.;
Antonia, Scott J.

Publication type:

Article

Racial Differences in Lung Cancer Screening Beliefs and Screening Adherence.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. 570, doi. 10.1016/j.cllc.2021.06.003

By:

Barta, Julie A.;
Shusted, Christine S.;
Ruane, Brooke;
Pimpinelli, Marcella;
McIntire, Russell K.;
Zeigler-Johnson, Charnita;
Myers, Ronald E.;
Evans, Nathaniel R.;
Kane, Gregory C.;
Juon, Hee-Soon

Publication type:

Article

Understanding Contemporary Molecular Biomarker Testing Rates and Trends for Metastatic NSCLC Among Community Oncologists.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. e901, doi. 10.1016/j.cllc.2021.05.006

By:

Waterhouse, David M.;
Tseng, Wan-Yu;
Espirito, Janet L.;
Robert, Nicholas J.

Publication type:

Article

Clinical Value and Pathologic Basis of Cystic Airspace Within Subsolid Nodules Confirmed as Lung Adenocarcinomas by Surgery.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. e881, doi. 10.1016/j.cllc.2021.05.005

By:

Wang, Bin;
Hamal, Preeti;
Sun, Ke;
Bhuva, Maheshkumar Satishkumar;
Yang, Yang;
Ai, Zisheng;
Sun, Xiwen

Publication type:

Article

Effect of Immune-Related Adverse Events and Pneumonitis on Prognosis in Advanced Non–Small Cell Lung Cancer: A Comprehensive Systematic Review and Meta-analysis.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. e889, doi. 10.1016/j.cllc.2021.05.004

By:

Li, Yanlin;
Zhang, Yajuan;
Jia, Xiaohui;
Jiang, Panpan;
Mao, Ziyang;
Liang, Ting;
Du, Yonghao;
Zhang, Jia;
Zhang, Guangjian;
Niu, Gang;
Guo, Hui

Publication type:

Article

Adverse Overall Survival Impact of PD-L1 Positivity in Patients With KRAS G12C Mutation Is Abolished by the Immunotherapy.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. e856, doi. 10.1016/j.cllc.2021.04.010

By:

Yu, James;
Du, Yuan;
Mekhail, Tarek;
Socinski, Mark A.;
Chang, Chung-Che

Publication type:

Article

Lung Adenocarcinoma With Primary LIMD1-BRAF Fusion Treated With MEK Inhibitor: A Case Report.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. e878, doi. 10.1016/j.cllc.2021.05.003

By:

Wang, Cheng-You;
Hsia, Jiun-Yi;
Li, Che-Hsing;
Ho, Chao-Chi;
Chao, Wan-Ru;
Wu, Ming-Fang

Publication type:

Article

Co-occurring MET Amplification Predicts Inferior Clinical Response to First-Line Erlotinib in Advanced Stage EGFR-Mutated NSCLC Patients.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. e870, doi. 10.1016/j.cllc.2021.05.002

By:

Clement, Michelle S.;
Ebert, Eva Boysen Fynboe;
Meldgaard, Peter;
Sorensen, Boe S.

Publication type:

Article

Risk Factors Associated with a Second Primary Lung Cancer in Patients with an Initial Primary Lung Cancer.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. e842, doi. 10.1016/j.cllc.2021.04.004

By:

Fisher, Amanda;
Kim, Seongho;
Farhat, Dina;
Belzer, Kimberly;
Milczuk, MaryAnn;
French, Courtney;
Mamdani, Hirva;
Sukari, Ammar;
Baciewicz, Frank;
Schwartz, Ann G.;
Wozniak, Antoinette;
Nagasaka, Misako

Publication type:

Article

Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878).

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. 541, doi. 10.1016/j.cllc.2021.05.001

By:

Riess, Jonathan W;
Reckamp, Karen L;
Frankel, Paul;
Longmate, Jeffrey;
Kelly, Karen A;
Gandara, David R;
Weipert, Caroline M;
Raymond, Victoria M;
Keer, Harold N;
Mack, Philip C;
Newman, Edward M;
Lara, Primo N

Publication type:

Article

Early Alectinib Resistance From MET Amplification in ALK-Rearranged NSCLC: Response to Crizotinib with Re-Response to Alectinib and Crizotinib.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. e851, doi. 10.1016/j.cllc.2021.04.008

By:

Ji, Jingran;
Mitra, Anupam;
Camidge, D. Ross;
Riess, Jonathan W.

Publication type:

Article

Bloodborne Cytokines for Predicting Clinical Benefits and Immune-Related Adverse Events in Advanced Non-Small Cell Lung Cancer Treated With Anti-Programmed Cell Death 1 Inhibitors.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. e833, doi. 10.1016/j.cllc.2021.04.007

By:

Oyanagi, Jun;
Koh, Yasuhiro;
Sato, Koichi;
Teraoka, Shunsuke;
Tokudome, Nahomi;
Hayata, Atsushi;
Akamatsu, Hiroaki;
Ozawa, Yuichi;
Nakanishi, Masanori;
Ueda, Hiroki;
Yamamoto, Nobuyuki

Publication type:

Article

Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non–small-cell Lung Cancer: SQUAT trial (WJOG 12119L).

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. 596, doi. 10.1016/j.cllc.2021.04.006

By:

Hamada, Akira;
Soh, Junichi;
Hata, Akito;
Nakamatsu, Kiyoshi;
Shimokawa, Mototsugu;
Yatabe, Yasushi;
Oizumi, Hiroyuki;
Tsuboi, Masahiro;
Horinouchi, Hidehito;
Yoshino, Ichiro;
Tanahashi, Masayuki;
Toyooka, Shinichi;
Okada, Morihito;
Yokomise, Hiroyasu;
Yamashita, Motohiro;
Nishimura, Yasumasa;
Yamamoto, Nobuyuki;
Nakagawa, Kazuhiko;
Mitsudomi, Tetsuya

Publication type:

Article

A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. 531, doi. 10.1016/j.cllc.2021.04.005

By:

Byers, Lauren Averett;
Navarro, Alejandro;
Schaefer, Eric;
Johnson, Melissa;
Özgüroğlu, Mustafa;
Han, Ji-Youn;
Bondarenko, Igor;
Cicin, Irfan;
Dragnev, Konstantin H.;
Abel, Adam;
Wang, Xuejing;
McNeely, Samuel;
Hynes, Scott;
Lin, Aimee Bence;
Forster, Martin

Publication type:

Article

EGFR Exon 20 Insertion Mutations: Clinicopathological Characteristics and Treatment Outcomes in Advanced Non–Small Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. e859, doi. 10.1016/j.cllc.2021.04.009

By:

Leal, Jose Luis;
Alexander, Marliese;
Itchins, Malinda;
Wright, Gavin M.;
Kao, Steven;
Hughes, Brett G.M.;
Pavlakis, Nick;
Clarke, Stephen;
Gill, Anthony J;
Ainsworth, Hannah;
Solomon, Benjamin;
John, Thomas

Publication type:

Article

Impact of Clinical Trial Participation on Survival of Patients with Metastatic Non-Small Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. 523, doi. 10.1016/j.cllc.2021.04.003

By:

Merkhofer, Cristina M.;
Eaton, Keith D.;
Martins, Renato G.;
Ramsey, Scott D.;
Goulart, Bernardo H.L.

Publication type:

Article

Palmoplantar Pustulosis Caused by Immune-Checkpoint Inhibitors.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. e829, doi. 10.1016/j.cllc.2021.04.002

By:

Furuta, Hiromi;
Kato, Seiichi;
Masago, Katsuhiro;
Hida, Toyoaki

Publication type:

Article

Micropapillary Predominance Is a Risk Factor for Brain Metastasis in Resected Lung Adenocarcinoma.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. e820, doi. 10.1016/j.cllc.2021.04.001

By:

Shigenobu, Takao;
Takahashi, Yusuke;
Masugi, Yohei;
Hanawa, Ryutaro;
Matsushita, Hirokazu;
Tajima, Atsushi;
Kuroda, Hiroaki

Publication type:

Article

EGFR L718V (+)/T790M (–) as a Mechanism of Resistance in Patients with Metastatic Non–small-cell Lung Cancer with EGFR L858R Mutations.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. e817, doi. 10.1016/j.cllc.2021.03.018

By:

Raez, Luis E.;
Carracedo, Carlos;
Drusbosky, Leylah M.;
Velez, Michel;
Carlisle, Jennifer;
Stinchcombe, Thomas

Publication type:

Article

Predictive Value of Combining Biomarkers for Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. 500, doi. 10.1016/j.cllc.2021.03.017

By:

Kao, Chester;
Powers, Eric;
Wu, Yuan;
Datto, Michael B.;
Green, Michelle F.;
Strickler, John H.;
Ready, Neal E.;
Zhang, Tian;
Clarke, Jeffrey M.

Publication type:

Article

Pulmonary Cylindromas in CYLD Cutaneous Syndrome: A Rare Differential Diagnosis of Pulmonary Adenoid Cystic Carcinoma.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. e795, doi. 10.1016/j.cllc.2021.03.016

By:

Bülau, Judith E.;
Kreipe, Hans-Heinrich;
Jessen, Ellen;
von Hardenberg, Sandra;
Auber, Bernd;
Grohé, Christian;
Leo, Fabian

Publication type:

Article

Association of Carcinoembryonic Antigen Reduction With Progression-free and Overall Survival Improvement in Advanced Non-small-cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. 510, doi. 10.1016/j.cllc.2021.03.014

By:

Arrieta, Oscar;
Varela-Santoyo, Edgar;
Cardona, Andrés F.;
Sánchez-Reyes, Roberto;
Lara-Mejía, Luis;
Bassarmal, Suraj Samtani;
Valle-Bautista, Dafne;
Corrales-Rodríguez, Luis;
Motola-Kuba, Daniel;
Cabrera-Miranda, Luis;
Martín, Claudio

Publication type:

Article

A Case of Small Cell Lung Carcinoma Harboring an EML4–ALK Fusion with Partial Response to Crizotinib.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. e799, doi. 10.1016/j.cllc.2021.03.012

By:

Shen, Qian;
Kalyani, Farhin Shaheed;
Qu, Jingjing;
Chen, Zhen;
Zhang, Jing;
Zhou, Jianying

Publication type:

Article

Utility of Prophylactic Cranial Irradiation for Extensive-Stage Small-Cell Lung Cancer in the MRI Screening Era.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. e808, doi. 10.1016/j.cllc.2021.03.009

By:

Keller, Andrew;
Ghanta, Siddharth;
Rodríguez-López, Joshua L.;
Patel, Ankur;
Beriwal, Sushil

Publication type:

Article

Black Hairy Tongue After Immune Checkpoint Inhibitors in NSCLC: A Case Report and Review of the Literature.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. e804, doi. 10.1016/j.cllc.2021.03.008

By:

Cecchi, Cristina;
Mariniello, Annapaola;
Carnio, Simona;
Delcuratolo, Marco D.;
Novello, Silvia

Publication type:

Article

Description of a Lung Cancer Hotspot: Disparities in Lung Cancer Histology, Incidence, and Survival in Kentucky and Appalachian Kentucky.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. e911, doi. 10.1016/j.cllc.2021.03.007

By:

Brainson, Christine F.;
Huang, Bin;
Chen, Quan;
McLouth, Laurie E.;
He, Chunyan;
Hao, Zhonglin;
Arnold, Susanne M.;
Zinner, Ralph G.;
Mullett, Timothy W.;
Bocklage, Therese J.;
Orren, David K.;
Villano, John L.;
Durbin, Eric B.

Publication type:

Article

A Randomized Phase III Study of Pembrolizumab Versus Pembrolizumab-Carboplatin-Pemetrexed for Locally Advanced or Metastatic Nonsquamous Non-small-cell Lung Cancer with PD-L1 50% or more (LAPLACE-50): Study Protocol.

Published in:

Clinical Lung Cancer, 2021, v. 22, n. 6, p. e921, doi. 10.1016/j.cllc.2021.02.008

By:

Kogure, Yoshihito;
Hashimoto, Hiroya;
Oki, Masahide

Publication type:

Article